Christopher R.J.Pace (Chris)

Partner

(T) + 1.305.714.9730

Chris Pace has tried and prevailed in more than 20 cases, and he has orally argued and prevailed in over 25 appeals. Chris represents clients in commercial disputes, trade secrets and unfair competition cases, money laundering and other criminal investigations and prosecutions, and federal antitrust and RICO actions (Racketeer Influenced and Corrupt Organizations Act).

Chris has appeared on behalf of Fortune 500 companies in cases across the country, including in multidistrict litigation proceedings. He has represented health care-related entities on numerous occasions in class actions, commercial disputes, and investigations by the Department of Justice, state attorneys general, and regulatory agencies. Chris also has frequently been engaged by both corporations and individuals to investigate, or defend against, allegations of money laundering, trade secrets misappropriation, and bribery/corruption.

Prior to joining Jones Day, Chris had a diverse career that included service as an Assistant United States Attorney for the Southern District of Florida and as a law clerk to Supreme Court Justice Anthony M. Kennedy. He is a member of the Florida, California, District of Columbia, New York, and Texas bars.

Experience

  • Stars Group and FOX Sports launch FOX Bet, the first-of-its kind national media and sports wagering partnership in U.S.Jones Day advised The Stars Group Inc. (Nasdaq: TSG) (TSX: TSGI) on its transaction with FOX Sports, a unit of Fox Corporation (Nasdaq: FOXA), to launch FOX Bet, the first-of-its kind national media and sports wagering partnership in the United States.
  • Fidelity obtains dismissal of all claims relating to alleged filing of suspicious activity report, affirmed by First CircuitJones Day obtained a significant victory on behalf of Fidelity Brokerage Services, LLC in a lawsuit brought by two former Fidelity customers and their investment advisor.
  • Major university conducts internal investigation relating to DOJ probe into corruption and fraud in Division I men's college basketballJones Day has been retained by a major university to conduct an independent investigation relating to a Department of Justice probe into corruption and fraud in Division I men’s college basketball, as well as to assist the university in its responses to the Justice Department probe and a related NCAA investigation.
  • Nuclear Energy Institute defeats NextEra Energy lawsuit claiming rights to NEI’s member-only data systemJones Day obtained a significant victory on behalf Nuclear Energy Institute, Inc. ("NEI"), a trade association for companies involved in the generation and application of nuclear power.
  • All-cargo carrier successfully defends against claims seeking millions of dollars in damagesJones Day represented an all-cargo carrier in connection with a lawsuit filed by a plaintiff who was injured by falling cargo in the warehouse of a ground services handling agent.
  • Investors resolve dispute with claimed inventor of low energy nuclear reaction deviceJones Day represented an investment company, two alternative energy technology companies, and two executives in connection with litigation brought by Andrea Rossi and Leonardo Corporation.
  • TECO Energy, Tampa Electric, and New Mexico Gas secure voluntary dismissal pre-discovery after identifying strong non-infringement argumentsOn behalf of TECO Energy, Inc., Tampa Electric Co., and New Mexico Gas Co., Jones Day secured a voluntary dismissal after filing a motion to dismiss and identifying strong non-infringement arguments before discovery started in the case.
  • ResMed successfully resolves antitrust litigation brought by competitorJones Day represented ResMed Corp. in connection with antitrust litigation brought by 3B Medical, Inc. alleging monopolization and exclusive dealing.
  • Procter & Gamble defends multidistrict product liability litigation over allegations surrounding neurological effects of long-term dental cream useJones Day is representing The Procter & Gamble Company, The Procter & Gamble Distributing, LLC, and The Procter & Gamble Manufacturing Company in a multidistrict litigation in which plaintiffs allege that long-term use of P&G's dental cream can cause neurological damage.
  • Seller of oil field concessions defends FCPA investigationJones Day is representing an individual who is being investigated by the U.S. Securities and Exchange Commission for alleged violations of the Foreign Corrupt Practices Act in relation to the sale of certain oil field concessions in Argentina.
  • SFAC sells property in Miami Beach for $88 millionJones Day assisted the South Florida Art Center, Inc. ("SFAC") in the $88 million sale of its property at 800 Lincoln Road in Miami Beach, Florida.
  • Investment bank secures dismissal of claims brought against it by Florida Gaming and also recovers on its proof of claim against Florida GamingJones Day represented a boutique investment bank both in securing the dismissal of claims brought against it by Florida Gaming Centers and Florida Gaming Corporation, and in prosecuting a contingent claim against the Florida Gaming parties in their ensuing bankruptcy proceedings.
  • The following represents experience acquired prior to joining Jones Day.

    Secured summary judgment for a health insurer/managed care company against a nationwide certified class of health care providers who alleged that the company conspired with other insurers to under-reimburse the providers. Also represented the company on a successful appeal upholding the summary judgment award. At an earlier stage in the litigation, the case involved a successful petition for certiorari to the U.S. Supreme Court, which reversed a court of appeals decision and held that certain of the provider plaintiffs' claims against the company needed to be resolved in arbitration.

    Defeated antitrust and RICO claims brought against a health insurer/managed care company and a health care technology company in a California multidistrict litigation proceeding and a separate New Jersey case. The plaintiffs alleged in their claims that the companies engaged in nationwide conspiracies to suppress the amounts that out-of-network health care providers were reimbursed for their services.

    Represented investment bank in action brought by commercial bank alleging that investment bank stole commercial bank's trade secrets and largest clients in a South American country. Obtained ruling from federal district court reversing ex parte temporary restraining order and holding that law of the South American country had to apply to commercial bank's claims, including its theft of trade secrets claim. Case thereafter resolved by confidential settlement.

    Conducted internal investigation for financial services company into reports of bribes and improper payments to foreign officials (and associated money laundering) by intermediaries and advising on appropriate action to take in connection with intermediaries as a result of investigation.

    Conducted internal investigation for conglomerate company into allegations of bid-rigging involving one of the company's subsidiaries. Following investigation and disclosure to the government, subsidiary resolved bid-rigging issues civilly, without criminal charges being brought.

    Defeated motion for preliminary injunction brought against real estate development company following several days of evidentiary hearings. Motion sought to enjoin company's sale of real estate project to highest bidder at auction after original sale of project failed to close. Judgment later entered affirming company's right to sell project to highest bidder.

    Represented general counsel of health care company in connection with Department of Justice and Securities & Exchange Commission investigations into potential criminal and civil violations over the operation of the company and its eventual failure. Investigation resolved with no criminal or SEC charges filed against general counsel.

    Represented former investment banker in connection with grand jury investigation into alleged fraud and improper payments to government officials in connection with swap agreements entered by governmental entity. Investigation resolved without criminal or civil charges being brought against investment banker.

    Represented consumer products company in a false advertising class action in Florida federal court. Prevailed on motion to dismiss against the plaintiff's false advertising claims. Thereafter defeated the plaintiff's motion to certify a class as to the remaining claims because the decision to purchase the product at issue involved many individualized variables. Plaintiff dismissed lawsuit after losing class certification.

    Represented a pharmacy benefits manager in a federal grand jury investigations into whether various pharmaceutical manufacturers violated "best price" or kickback provisions of federal law as a result of their arrangements with company, which resulted in no charges brought against either the pharmacy benefits manager or its employees.

    Speaking Engagements

    • April 4, 2017
      Emerging Trends in Consumer Fraud Class Action Litigation
    • February 26, 2015
      Answering the Door When the Government Knocks: Effectively Responding to Government Investigations
    • October 22, 2013
      Overcoming Challenges to Implementing and Preparing for New Litigation Risks in Light of the Affordable Care Act (ACA), American Conference Institute’s 4th Annual Advanced Forum on Managed Care Disputes and Litigation – Southern Edition
    • May 22, 2012
      Defending Against Class Action Lawsuits in an Era of Increased Litigiousness: Medical Necessity, Beneficiaries and Privacy, American Conference Institute’s 2nd Advanced Forum on Managed Care Disputes & Litigation
    • March 16, 2012
      Failing Lenders: Dueling Bankruptcy Cases, Bank Holding Company Debtors, and Other Key Issues, American Bankruptcy Institute's Bankruptcy Battleground West Conference
    • November 9, 2011
      Analyzing and Defending Against the New Theories Espoused By Plaintiffs to Certify a Class, American Conference Institute's Managed Care Disputes and Litigation Forum
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.